Showing results (1-10 of 509) with videos related to
Sort By:
Pageof 51
Urology Journal|October 1, 2013
Mirabegron for overactive bladder: a novel, first-in-class β3-agonist therapyMohammed Imran, Abul Kalam Najmi, Shams TabrezJournal of Mid-Life Health|January 2, 2014
Hippocratic oath and conversion of ethico-regulatory aspects onto doctors as a physician, private individual and a clinical investigatorMohammed Imran, Shadab Samad, Mohammad Maaz, et al.Expert Opinion on Therapeutic Targets|January 30, 2013
Effects of pioglitazone and vildagliptin on coagulation cascade in diabetes mellitus--targeting thrombogenesisSana Khan, Saba Khan, Mohammed Imran, et al.Current Drug Targets|August 17, 2018
Novel Therapeutic Potential of Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) in Chronic Airway Inflammatory DisordersRakesh Kumar Singh, Abul Kalam NajmiEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 18, 2016
Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspectiveTushar Madaan, Mohd Akhtar, Abul Kalam NajmiJournal of Evidence-Based Medicine|November 27, 2019
Anemia prevalence and its impact on health-related quality of life in Indian diabetic kidney disease patients: Evidence from a cross-sectional studySalman Hussain, Anwar Habib, Abul Kalam NajmiAssay and Drug Development Technologies|March 10, 2026
Neprilysin Inhibitor and Angiotensin Receptor Blocker Attenuate Ischemic Brain Injury: Unveiling the Kinin-Mediated PathwayGeetika Mehta, Monika Sachdeva, Abul Kalam NajmiDrug Research|October 9, 2018
A Natural Phenolic Compound Quercetin Showed the Usefulness by Targeting Inflammatory, Oxidative Stress Markers and Augment 5-HT Levels in One of the Animal Models of Depression in MiceKhadeeja Khan, Abul Kalam Najmi, Mohd AkhtarInternational Journal of Environmental Research and Public Health|April 26, 2019
Limited Knowledge of Chronic Kidney Disease among Type 2 Diabetes Mellitus Patients in IndiaSalman Hussain, Anwar Habib, Abul Kalam NajmiJournal of Evidence-Based Medicine|December 2, 2017
Role of Cochrane Reviews in informing US private payers' policiesAmbrish Singh, Salman Hussain, Abul Kalam NajmiPageof 51